Technologies
Arbutus Biopharma Corp (NASDAQ:ABUS) jumps 29.61% In 2025; How Attractive Is It At $3.13?
In last trading session, Arbutus Biopharma Corp (NASDAQ:ABUS) saw 0.89 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price
